In their meta-analysis, Mo and co-workers 2009 found that the GSTM1 deletion increased the risk of prostate cancer in the general population, including Asians, Afro-Americans, and populations of African and Caucasian descent. The gene discussed is GSTM1; the disease is prostate carcinoma.